DepoCyt formulation of cytarabine in DepoFoam data

DEPO and partner Chiron Corp. (CHIR, Emeryville, Calif.) announced further Phase III findings in

Read the full 145 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE